Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    March 2017
  1. HENNON M, Landreneau RJ
    Role of Segmentectomy in Treatment of Early-Stage Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5787.
    PubMed     Text format     Abstract available


    February 2017
  2. YOUNG KA, Efiong E, Dove JT, Blansfield JA, et al
    External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-017-5795.
    PubMed     Text format     Abstract available


  3. PEZZI TA, Mohamed AS, Fuller CD, Blanchard P, et al
    Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2017 Feb 2. doi: 10.1245/s10434-017-5786.
    PubMed     Text format     Abstract available


    October 2016
  4. NOJIRI T, Hamasaki T, Inoue M, Shintani Y, et al
    Long-Term Impact of Postoperative Complications on Cancer Recurrence Following Lung Cancer Surgery.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  5. SHIMAMATSU S, Okamoto T, Haro A, Kitahara H, et al
    Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  6. SAMAYOA AX, Pezzi TA, Pezzi CM, Greer Gay E, et al
    Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  7. KANZAKI R, Naito H, Kise K, Takara K, et al
    PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  8. KUSAMURA S, Torres Mesa PA, Cabras A, Baratti D, et al
    The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2016;23:1468-73.
    PubMed     Text format     Abstract available


  9. JUDGE S, Thomas P, Govindarajan V, Sharma P, et al
    Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.
    Ann Surg Oncol. 2016;23:1496-500.
    PubMed     Text format     Abstract available


    April 2016
  10. ZHANG F, Zheng W, Ying L, Wu J, et al
    A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  11. BU S, Wang R, Pan Y, Yu S, et al
    Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  12. LIU SR, Qiu B, Yang H, Liang Y, et al
    Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  13. WANG BY, Huang JY, Ko JL, Lin CH, et al
    A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  14. ANDREOU D, Gilg MM, Gosheger G, Werner M, et al
    Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
    Ann Surg Oncol. 2016;23:120-5.
    PubMed     Text format     Abstract available


    October 2015
  15. PARK HS, Jung M, Shin SJ, Heo SJ, et al
    Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  16. SHOJI F, Yamazaki K, Kouso H, Mori R, et al
    Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  17. AZZOLI CG
    Practical Value of Molecular Pathology in Stage I-III Lung Cancer: Implications for the Clinical Surgeon.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  18. TAKAHASHI Y, Horio H, Hato T, Harada M, et al
    Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  19. IWATA S, Yonemoto T, Iizasa T, Niibe Y, et al
    Oligo-Recurrence of Osteosarcoma Patients: Treatment Strategies for Pulmonary Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  20. YEO CD, Park GS, Kang N, Choi SY, et al
    Erratum to: Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


  21. LIN TC, Lin PL, Cheng YW, Wu TC, et al
    MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  22. YEO CD, Park GS, Kang N, Choi SY, et al
    Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  23. MIMAE T, Suzuki K, Tsuboi M, Nagai K, et al
    Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  24. POLANCO PM, Ding Y, Knox JM, Ramalingam L, et al
    Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.
    Ann Surg Oncol. 2015;22:1673-9.
    PubMed     Text format     Abstract available


  25. MISE Y, Kopetz S, Mehran RJ, Aloia TA, et al
    Is complete liver resection without resection of synchronous lung metastases justified?
    Ann Surg Oncol. 2015;22:1585-92.
    PubMed     Text format     Abstract available


    February 2015
  26. MADANI A, Jozaghi Y, Tabah R, How J, et al
    Rare metastases of well-differentiated thyroid cancers: a systematic review.
    Ann Surg Oncol. 2015;22:460-6.
    PubMed     Text format     Abstract available


  27. KURITZKES B, Parikh M, Melamed J, Hindman N, et al
    False-positive rate of positron emission tomography/computed tomography for presumed solitary metastatic adrenal disease in patients with known malignancy.
    Ann Surg Oncol. 2015;22:437-40.
    PubMed     Text format     Abstract available


    September 2014
  28. NORDHOLM-CARSTENSEN A, Jorgensen LN, Wille-Jorgensen PA, Hansen H, et al
    Indeterminate Pulmonary Nodules in Colorectal-Cancer: Do Radiologists Agree?
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: